Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/3393
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDe Zoysa, M.I.M.
dc.contributor.authorSamarasekera, D.N.
dc.contributor.authorSenarath, L.D.J.U.
dc.contributor.authorSamarasekera, C.A.
dc.contributor.authorReid, C.B.
dc.contributor.authorLokuhetty, M.D.S.
dc.date.accessioned2012-12-20T07:55:09Z
dc.date.available2012-12-20T07:55:09Z
dc.date.issued2012
dc.identifier.citationAnnual Research Symposiumen_US
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/3393-
dc.description.abstractColon carcinoma has a worldwide incidence of over one million with a 5 year survival rate of <20% for metastatic disease. Identification of metastasis related biomarkers will enable risk evaluation of metastasis in colon carcinoma.
dc.language.isoenen_US
dc.titlePathological significance of Epidermal Growth Factor Receptor (EGFR), Vascular Endothelial Growth Factor (VEGF), Chemokine Receptor 4 (CXCR4) and Vimentin expression by colon carcinoma cellsen_US
dc.typeResearch abstracten_US
Appears in Collections:Medicine

Files in This Item:
File Description SizeFormat 
AnnualResearchSymposium2012UniversityofColombo.241.pdf22.83 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.